COMIRNATY 30 MCG / 0.3 ML
*SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER : 30 MCG / 0.3 ML · DIN 02552035 · BIONTECH MANUFACTURING GMBH
Health Canada status: MARKETED
What is COMIRNATY?
COMIRNATY 30 MCG / 0.3 ML contains *SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER : 30 MCG / 0.3 ML. It is listed in the Health Canada Drug Product Database under DIN 02552035, held by BIONTECH MANUFACTURING GMBH, supplied as SUSPENSION for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 03-Sep-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is COMIRNATY used for?
Active immunization against coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in individuals 6 months of age and older.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02552035 |
|---|---|
| Brand name | COMIRNATY |
| Generic / active ingredient | *SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER : 30 MCG / 0.3 ML |
| Manufacturer | BIONTECH MANUFACTURING GMBH |
| Strength | 30 MCG / 0.3 ML |
| Dosage form | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Schedule D |
| ATC code | J07BN01 COVID-19, RNA-BASED VACCINE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 03-Sep-2025 |
How is it stored and handled?
After dilution for yellow cap vials: Store between 2°C to 25°C (35°F to 77°F) and use within 12 hours. For gray/blue cap vials after first puncture: Store between 2°C to 25°C (35°F to 77°F) and use within 12 hours. Prefilled syringes: Store for up to 12 hours between 8°C to 25°C.
How is it supplied?
Single Dose Vial: 30 mcg/0.3 mL, 10 mcg/0.3 mL; Multiple Dose Vial: 30 mcg/0.3 mL (6 doses/vial), 10 mcg/0.3 mL (6 doses/vial), 3 mcg/0.3 mL (3 doses/vial after dilution); Single Dose Prefilled Syringe: 30 mcg/0.3 mL
What can be used instead?
Other Canadian products sharing ATC code J07BN01 COVID-19, RNA-BASED VACCINE. 5 of 20 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| COMIRNATY | 10 MCG / 0.3 ML | SUSPENSION | BIONTECH MANUFACTURING GMBH | MARKETED | DIN 02541858 |
| COMIRNATY | 30 MCG / 0.3 ML | SUSPENSION | BIONTECH MANUFACTURING GMBH | MARKETED | DIN 02541823 |
| SPIKEVAX | 0.1 MG | DISPERSION | MODERNA BIOPHARMA CANADA CORPORATION | MARKETED | DIN 02541270 |
| SPIKEVAX | 50 MCG / 0.5 ML | DISPERSION | MODERNA BIOPHARMA CANADA CORPORATION | MARKETED | DIN 02557770 |
| COMIRNATY | 10 MCG / 0.2 ML | SUSPENSION | BIONTECH MANUFACTURING GMBH | CANCELLED POST MARKET | DIN 02522454 |
| COMIRNATY | 3 MCG / 0.2 ML | SUSPENSION | BIONTECH MANUFACTURING GMBH | CANCELLED POST MARKET | DIN 02530325 |
| COMIRNATY | 3 MCG / 0.3 ML | SUSPENSION | BIONTECH MANUFACTURING GMBH | APPROVED | DIN 02552078 |
| COMIRNATY | 30 MCG / 0.3 ML | SUSPENSION | BIONTECH MANUFACTURING GMBH | CANCELLED POST MARKET | DIN 02509210 |
| COMIRNATY | 30 MCG / 0.3 ML | SUSPENSION | BIONTECH MANUFACTURING GMBH | CANCELLED POST MARKET | DIN 02527863 |
| COMIRNATY OMICRON XBB.1.5 | 10 MCG / 0.2 ML | SUSPENSION | BIONTECH MANUFACTURING GMBH | CANCELLED PRE MARKET | DIN 02541831 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.